Search clinical trials for: hATG

Total 441 results

The Methodist Hospital Research Institute

Unknown

Single Dose rATG for Renal Allograft Rejection

Acute (Cellular) Renal Allograft Rejection

United States
Haus Bioceuticals

Completed

Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic
Soonchunhyang University Hospital

Unknown

Laparoscopy-assisted Total Gastrectomy for Clinical Stage I Gastric Cancer (KLASS-03) (KLASS-03)

Gastric Cancer

Korea, Republic of
Humacyte, Inc.
FGK Clinical Research GmbH; Aptiv Solutions

Completed

Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease

Kidney Failure, Chronic | End-stage Renal Disease

United States
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effectiveness of Home Automated Telemanagement in Chronic Obstructive Pulmonary Disorder

Pulmonary Disease, Chronic Obstructive

United States
Antengene Corporation

Terminated

A Study of ATG-010 in Combination With ATG-008 in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (MATCH)

Relapsed/Refractory Diffuse Large B-cell Lymphoma

China
IRCCS Burlo Garofolo

Completed

Lymphocyte Count, ATG Dose and Incidence and Severity of GVHD in Pediatric Recipients of HSCT

Hematopoietic Stem Cell Transplantation

Italy
European Society for Blood and Marrow Transplantation
Novartis; Pfizer

Completed

hATG+CsA vs hATG+CsA+Eltrombopag for SAA (RACE)

Severe Aplastic Anemia

Switzerland, Netherlands, France, Italy, Spain, United Kingdom
National Heart, Lung, and Blood Institute (NHLBI)
Novartis

Recruiting

Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

Severe Aplastic Anemia

United States
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN)

Terminated

Study of Antithymocyte Globulin for Treatment of New-onset T1DM (START)

New-onset Type 1 Diabetes Mellitus

United States
Qi Zhou

Not yet recruiting

A Study to Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH ) (PORCH)

1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer

China
Antengene (Hangzhou) Biologics Co., Ltd.

Recruiting

A Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas

Advanced Solid Tumor | Metastatic Solid Tumor | Mature B-cell Non-Hodgkin Lymphoma

China
Novartis Pharmaceuticals

Active, not recruiting

A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia

Aplastic Anemia

Thailand, Russian Federation, Portugal, United Kingdom, Hong Kong, United States
Antengene Biologics Limited

Not yet recruiting

A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas

Advanced Solid Tumors | B-cell Non-Hodgkin Lymphomas
Antengene Biologics Limited

Recruiting

A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors (CLINCH)

Advanced/Metastatic Solid Tumors

China, Australia
Shanghai Antengene Corporation Limited

Terminated

A Study to Evaluating the Pharmacokinetics, Safety, and Efficacy of ATG 016 Monotherapy in IPSS-R Intermediate Risk and Above Myelodysplastic Syndrome (MDS) (HATCH)

Myelodysplastic Syndrome

China
Antengene Therapeutics Limited

Terminated

Dual TORC1/TORC2 Inhibitor ATG-008 (CC-223) in HBV Positive Advanced Hepatocellular Carcinoma (HCC) Subjects

Hepatocellular Carcinoma

Korea, Republic of, Taiwan, China
Antengene Discovery Limited

Recruiting

A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies (ATRIUM)

Advanced Solid Tumors | Hematological Malignancies

Australia
Shanghai Antengene Corporation Limited

Terminated

A Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG 016 Monotherapy in Patients With Advanced Solid Tumors (REACH)

Advanced Solid Tumors

China
Sorin Group USA, Inc.

Terminated

CarboMedics Top Hat vs St. Jude Medical Regent Valve Comparing Sizing and Hemodynamics

Aortic Valve Disease

United States
Humacyte, Inc.
FGK Clinical Research GmbH

Active, not recruiting

Evaluation of the Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With ESRD

Kidney Failure, Chronic | End-stage Renal Disease

Poland
Shanghai General Hospital, Shanghai Jiao Tong University...

Completed

ATG/PTCy in Haplo-PBSCT Randomized Controlled,Multi-center (ATG/PTCy)

Myeloid Tumor

China
University of South Florida

Completed

Sun Protection for Florida's Children

Skin Cancer

United States
M.D. Anderson Cancer Center

Completed

Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases

Lymphoma | Leukemia

United States
University Hospital Tuebingen
Haag-Streit AG

Completed

Age-related Normative Values for the Octopus 900 Perimeter (Norm-Oct900)

Healthy

Germany
Shanghai Antengene Corporation Limited

Terminated

A Study of Evaluating the Safety and Efficacy of ATG-008 for Advanced Solid Tumors (BUNCH)

Advanced Solid Tumors

China
European Society for Blood and Marrow Transplantation

Enrolling by invitation

RACE 2: a Long Term Follow-up of Patients Participating in the RACE Trial (RACE2)

Severe Aplastic Anemia

France
IDinsight
National Malaria Control Centre, Zambia; Ministry of Health, Zambia; Clinton...

Completed

Community Point Distribution of Insecticide Treated Bed Nets

Malaria
University of Nottingham
Heartlight Systems Limited

Completed

HeartLight: Heart Rate Monitoring for Newborn Resuscitation (HeartLight)

Infant, Newborn, Diseases | Infant, Premature, Diseases | Fetus or Neonate Affected by Cesarean Section

United Kingdom
Guangdong Provincial Hospital of Traditional Chinese...

Unknown

Laparoscopic-assisted Total Gastrectomy Versus Open Total Gastrectomy With Splenic Hilum Lymph Nodes Dissection

Gastric Cancer | Splenic Hilum Lymph Nodes Dissection | Total Gastrectomy

China
Haag Streit USA

Completed

Time Study for Biometry Measurements With the Lenstar and IntraOcularLens (IOL) Master 500

Pseudoaphakia

United States
M.D. Anderson Cancer Center
Genzyme, a Sanofi Company

Terminated

Thymoglobulin (ATG) Dose Finding Study

Graft vs Host Disease

United States
Hospital Universitari de Bellvitge

Recruiting

Hand Acceleration Time (HAT) Assessment Before and After Creating an Arteriovenous Fistula (AVF) (HATs-ACCVAS)

Vascular Diseases | Arteriovenous Fistula

Spain
National Institute of Blood Disease Center, Pakistan

Unknown

Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia (ATG)

Aplastic Anemia

Pakistan
Antengene Biologics Limited

Recruiting

A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas (PROBE)

Advanced Solid Tumor | Metastatic Solid Tumor | Mature B-cell Non-Hodgkin Lymphoma

United States, Australia
IRCCS Policlinico S. Matteo
Italian Association for Pediatric Hematology Oncology

Unknown

Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation (ATG FRES)

Paediatric Patients Affected by Haematological Malignancies and Eligible to Undergo HSCT From an Unrelated Volunteer

Italy
The First Affiliated Hospital of Soochow University

Recruiting

Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation

Acute Leukemia | Hematopoietic Stem Cell Transplantation

China
Hadassah Medical Organization

Terminated

A Study to Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCT

Graft Versus Host Disease | Allogeneic Haplo-Stem Cell Transplatation (SCT)

Israel
Astellas Pharma Inc

Completed

Efficacy and Safety of Two Anti-T-lymphocyte Immune Globulin (ATG-F) Induction Regimens in Anew Kidney Transplant Patients

De Novo Kidney Transplant Patients

China
Ohio State University Comprehensive Cancer Center
Celgene Corporation

Recruiting

Romidepsin Maintenance After Allogeneic Stem Cell Transplantation

Cutaneous T-cell Lymphoma | Peripheral T-Cell Lymphoma | T-Prolymphocytic Leukemia | T-Large Granulocytic Leukemia | T-Lymphoblastic Leukemia/Lymphoma

United States
Sichuan University

Recruiting

ATG-008 Combined With Toripalimab in Advanced Solid Tumors

Advanced Solid Tumor

China
Prof. Claude Pichard

Completed

Validation of the New HAG-B19 Scale for Measuring Lean and Fat Body Masse (HAG-BIA)

Body Composition

Switzerland
Nidek Co. LTD.

Completed

Comparative Study of the NIDEK TONOREF III and the Haag-Streit Goldmann Manual Tonometer and Comparison of Pachymetry Values for NIDEK TONOREF III With the NIDEK CEM-530

Intraocular Pressure

United States
Emory University
National Institute on Aging (NIA)

Completed

Faith-Based Toolbox for African Americans With Dementia

Dementia | Alzheimer Disease

United States
Kafrelsheikh University

Completed

Ridge Augmentation With Simultaneous Implant Placement Using Bone Blocks With Autogenous Tooth Graft

Implant | Ridge Augmentation | Autogenous Tooth Graft

Egypt
AZ-VUB

Unknown

Long-term Function of Beta Cell Allografts in Non-uremic Type 1 Diabetic Patients

Diabetes Mellitus, Type 1

Belgium
Nanfang Hospital of Southern Medical University

Recruiting

ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis

Hematopoietic Stem Cell Transplantation

China
Nidek Co. LTD.

Not yet recruiting

Comparative Study of the NIDEK TONOREF III With Predicate Devices

Intraocular Pressure

United Kingdom
Oslo University Hospital
The Research Council of Norway; Swedish-Norwegian Foundation for Equine Research

Completed

YATEP - The Impact of Horse Assisted Therapy (HAT) on Treatment Outcomes (HAT)

Addiction

Norway
University of Maryland
Baltimore VA Medical Center

Completed

Physical Telerehabilitation in Veterans With Multiple Sclerosis

Multiple Sclerosis

United States

Search clinical trials for: hATG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations